CSIMarket Company Name, Ticker, Industry, else..
 
Skye Bioscience Inc   (NASDAQ: SKYE)
 

SKYE's Market share relative to its competitors, as of Q1 2026

As of Q1 2026 (Revenue in Millions of $)

Date modified: 2026-09-10T18:18:47+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months
Q1 2026		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE
A Quarter Before
Q4 2025
Skye Bioscience Inc 0.00 0.00% 0.00 % 0.00 %
Abbvie Inc 64,386.00 20.44% 21.36% 9.88%
Pfizer Inc 63,696.00 20.22% 18.90% 9.52%
Astrazeneca Plc 58,739.00 18.65% 18.65% 35.62%
Novartis Ag 56,674.00 17.99% 17.99% 34.07%
Amgen Inc 38,095.00 12.09% 12.64% 5.68%
57 more competitors available

Sign in to see all competitors for Skye Bioscience Inc .

Sign In Create Free Account



SKYE's Market share relative to its competitors, as of Q1 2026 within the Major Pharmaceutical Preparations Industry
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE

Q4 2025
Skye Bioscience Inc 0.00% 0.00% 0.00 % 0.00 %
Abbvie Inc 24.20% 25.77% 25.46% 10.67%
Pfizer Inc 23.94% 26.37% 22.53% 10.28%
Astrazeneca Plc 22.07% 19.31% 22.07% 38.47%
Novartis Ag 21.30% 19.66% 21.30% 36.80%
Vertex Pharmaceuticals Inc 4.73% 5.06% 5.00% 2.12%
53 more companies available

Sign in to see all industry competitors for Skye Bioscience Inc .

Sign In Create Free Account



SKYE's Market share relative to its competitors, as of Q1 2026 within the Healthcare Sector
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE

Q4 2025
Skye Bioscience Inc 0.00% 0.00% 0.00 % 0.00 %
Abbvie Inc 20.47% 21.79% 21.40% 9.89%
Pfizer Inc 20.25% 22.30% 18.94% 9.53%
Astrazeneca Plc 18.67% 16.32% 18.67% 35.65%
Novartis Ag 18.01% 16.63% 18.01% 34.10%
Amgen Inc 12.11% 11.91% 12.66% 5.68%
55 more companies available

Sign in to see all sector competitors for Skye Bioscience Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Skye Bioscience Inc's market divisions, geographic dispersion, segments, products, and services, visit Skye Bioscience Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.